Health Condition 1: K769- Liver disease, unspecified
Conditions
Interventions
Intervention1: Nil: Nil
Sponsors
Shravya
Eligibility
Inclusion criteria
Inclusion criteria: Adults above 18 years diagnosed with liver disease example cirrhosis, NAFLD, hepatitis, alcoholic liver disease, etc. Patients with and without prior history of DM. Patients with or without glucose metabolism disorder to allow comparison. Patients who are willing to undergo metabolic testing, such as fasting glucose, HbA1c and oral glucose tolerance test. Patients providing written informed consent for study participation.
Exclusion criteria
Exclusion criteria: Pregnant or lactating women, patient without liver disease, patients with severe cognitive impairment or psychiatric conditions that limit adherence to study protocols.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| This study aims to identify and manage blood sugar problems (glucose metabolism disorders) in people with liver disease. Early detection can help prevent complications, slow liver damage, and improve treatment. The findings may lead to better screening methods, personalized care, and lifestyle changes, reducing hospital visits, healthcare costs, and disease progression while improving overall health, quality of life, and long-term survival for patients.Timepoint: 6 Months | — |
Secondary
| Measure | Time frame |
|---|---|
| This study aims to identify and manage blood sugar problems (glucose metabolism disorders) in people with liver disease. Early detection can help prevent complications, slow liver damage, and improve treatment. The findings may lead to better screening methods, personalized care, and lifestyle changes, reducing hospital visits, healthcare costs, and disease progression while improving overall health, quality of life, and long-term survival for patients.Timepoint: 6 Months | — |
Countries
India
Contacts
Public ContactDr Divya V C
Karavali College of Pharmacy
Outcome results
None listed